706 related articles for article (PubMed ID: 26912360)
21. Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (
Bou Zerdan M; Ashok Kumar P; Haroun E; Srivastava N; Ross J; Sivapiragasam A
Oncotarget; 2023 Mar; 14():178-187. PubMed ID: 36913304
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of protein methylation in melanoma.
Limm K; Ott C; Wallner S; Mueller DW; Oefner P; Hellerbrand C; Bosserhoff AK
Eur J Cancer; 2013 Apr; 49(6):1305-13. PubMed ID: 23265702
[TBL] [Abstract][Full Text] [Related]
23. Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer.
Chang WH; Chen YJ; Hsiao YJ; Chiang CC; Wang CY; Chang YL; Hong QS; Lin CY; Lin SU; Chang GC; Chen HY; Chen YJ; Chen CH; Yang PC; Yu SL
EMBO Rep; 2022 Aug; 23(8):e54265. PubMed ID: 35766227
[TBL] [Abstract][Full Text] [Related]
24. Transition state analogue of MTAP extends lifespan of APC
Firestone RS; Feng M; Basu I; Peregrina K; Augenlicht LH; Schramm VL
Sci Rep; 2021 Apr; 11(1):8844. PubMed ID: 33893330
[TBL] [Abstract][Full Text] [Related]
25. Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
Lubin M; Lubin A
PLoS One; 2009 May; 4(5):e5735. PubMed ID: 19478948
[TBL] [Abstract][Full Text] [Related]
26. The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation.
Jacobs B; Schlögl S; Strobl CD; Völkl S; Stoll A; Mougiakakos D; Malmberg KJ; Mackensen A; Aigner M
Front Immunol; 2020; 11():2128. PubMed ID: 33123121
[TBL] [Abstract][Full Text] [Related]
27. Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.
Basu I; Locker J; Cassera MB; Belbin TJ; Merino EF; Dong X; Hemeon I; Evans GB; Guha C; Schramm VL
J Biol Chem; 2011 Feb; 286(6):4902-11. PubMed ID: 21135097
[TBL] [Abstract][Full Text] [Related]
28. MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.
Engstrom LD; Aranda R; Waters L; Moya K; Bowcut V; Vegar L; Trinh D; Hebbert A; Smith CR; Kulyk S; Lawson JD; He L; Hover LD; Fernandez-Banet J; Hallin J; Vanderpool D; Briere DM; Blaj A; Marx MA; Rodon J; Offin M; Arbour KC; Johnson ML; Kwiatkowski DJ; Jänne PA; Haddox CL; Papadopoulos KP; Henry JT; Leventakos K; Christensen JG; Shazer R; Olson P
Cancer Discov; 2023 Nov; 13(11):2412-2431. PubMed ID: 37552839
[TBL] [Abstract][Full Text] [Related]
29. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
30. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
31. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
[TBL] [Abstract][Full Text] [Related]
32. Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease.
Bigaud E; Corrales FJ
Mol Cell Proteomics; 2016 May; 15(5):1498-510. PubMed ID: 26819315
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
Gordon RB; Blackwell K; Emmerson BT
Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
[TBL] [Abstract][Full Text] [Related]
34. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry.
Stevens AP; Dettmer K; Wallner S; Bosserhoff AK; Oefner PJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):123-8. PubMed ID: 18996776
[TBL] [Abstract][Full Text] [Related]
36. Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.
Karikari CA; Mullendore M; Eshleman JR; Argani P; Leoni LM; Chattopadhyay S; Hidalgo M; Maitra A
Mol Cancer Ther; 2005 Dec; 4(12):1860-6. PubMed ID: 16373701
[TBL] [Abstract][Full Text] [Related]
37. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Christopher SA; Diegelman P; Porter CW; Kruger WD
Cancer Res; 2002 Nov; 62(22):6639-44. PubMed ID: 12438261
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Dominici C; Sgarioto N; Yu Z; Sesma-Sanz L; Masson JY; Richard S; Raynal NJ
Clin Epigenetics; 2021 Mar; 13(1):54. PubMed ID: 33691794
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic analysis of transition-state features in picomolar inhibitors of human 5'-methylthioadenosine phosphorylase.
Guan R; Tyler PC; Evans GB; Schramm VL
Biochemistry; 2013 Nov; 52(46):8313-22. PubMed ID: 24148083
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]